103 -3 (31/3) 2020 — Primov U.H., Mirzoyeva M.R., — TO APPECIATE THE CLINIC OF PATIENTS WHICH GOT SICK WITH THE INFEKTION OF COVID

TO APPECIATE THE CLINIC OF PATIENTS WHICH GOT SICK WITH THE INFEKTION OF COVID

Primov U.H. -Bukhara State Medical Institute, Uzbekistan, Infectional hospital of Bukhara region.

Mirzoyeva M.R. -Bukhara State Medical Institute, Uzbekistan, Infectional hospital of Bukhara region.

Keldiyorova Z.D. -Bukhara State Medical Institute, Uzbekistan, Infectional hospital of Bukhara region.

Resume

Viral infections have become one of the most acute problems in medicine in the 21st century. According to the World Health Organization, as of June 11, 2020, the total number of registered coronavirus infections worldwide was 7514481, 3540696 were cured, and 421458 deaths. In Uzbekistan, this indicator was 4869 people, the total number of people recovered  was 3758, and the total number  the dead amounted to 19 people.              We conducted a study       on 46 patients treated in the 9th department of the Bukhara regional infectious diseases hospital.

The results show that: One of the most unusual symptoms of coronavirus is loss of taste or smell. In 80% of our patients, the disease was also noted with general weakness, loss of appetite, taste disorders, cough, symptoms of bronchitis and tonsillitis. In the remaining 20% of patients, symptoms such as pneumonia, headache, chest pain, and diarrhea were added.

Key words: (covid-19), coronavirus, clinic, diagnosis, prevention

First page

429

Last page

432

For citation: Primov U.H., Mirzoyeva M.R., Keldiyorova Z.D., To appeciate the clinic of patients which got sick with the infektion of covid//New Day in Medicine 3(31)2020 429-432 https://cutt.ly/NxFaG8W

List of References

1. Львов Д.К., Руководство по вирусологии: Вирусные инфекции человека и животных. / М- Издательство “МИА”, 2013, – 1200 с: ил.-с. 599-624.
2. Dennis Kasper, Anthony Fauci “Harrison’s Infectious Diseases 2 ed” USA, Mc.Graw-Hill Education, English, 2013
3. Field JJ, Hoofnaglejh: Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436:967, 2005
4. Gish RG et al: Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: A two-year study. J Hepatol 43:60, 2005
5. Guy B et al. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. Vaccine, 2011, 29, 7229-7241.
6. Haydenfg: Antiviral drugs (other than antiretrovirals), in Principles and Practice of Infectious Diseases, 6th ed, JE Bennett et al (eds). Philadelphia, Elsevier Churchill Livingstone, 2005, pp 514-551
7. Laicl et al: Entecavir versus lamivudine for patients with HbeAg negative chronic hepatitis B. N Engl J Med 354:186, 2006
8. Mungerk et al: Viral carcinogenesis and genomic instability. EXS 96:179, 2006
9. Treanorjj et al: Efficacy and safety in treating acute influenza: A randomized controlled trial. U.S. Oral Neuraminidase Study Group. JAMA 283:1016, 2006
10. Voss, Jameson D.; Atkinson, Richard L.; Dhurandhar, Nikhil V. (2015).”Role of adenoviruses in obesity”.Medical Virology 25 (6): 379-387.doi:10. 1002/rmv.1852. PMID 26352001.
11. Harrison, S. C. (2010). “Virology. Looking inside denovirus”. Science 329 (5995): 1026- 1027.Bibcode:2010Sci 329.1026H.doi:10.1126/ science. 1194922. PMID 20798308.
12. Goldstein, T.; Colegrove, K. M.; Hanson, M.; Gulland, F. M. D. (2011). “Isolation of a novel adenovirus from California sea lions Zalophus californianus”. Diseases of Aquatic Organisms 94 (3): 243-248.doi:10. 3354/dao02321. PMID 21790072.
13. J.L., Marquez-Jurado S., Andres G., Enjuanes L. Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. mBio. 2013; 4(5):e00650-13. doi: 10.1128/mBio.00650-13.
14. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A.,Al- Hajjar S., Al-Barrak A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013; 13(9):752-61.
15. Assiri A., McGeer A., Perl T.M., Price C.S., Al Rabeeah A.A. Cummings D.A., Assad M., Almulhim A.,Makhdoom H., Madani H., Alhakeem R., Al-Tawfiq J.A., Cotten M.,Watson S.J., Kellam P., Zumla A.I., Memish Z.A. Hospital outbrea of Middle East respiratory syndrome coronavirus. N. Engl. J. Med. 2013; 369(5):407- 16.
16. Belouzard S., Millet J.K., Licitra B.N., Whittaker G.R.Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012; 4:1011-33.
17. Bermingham A., Chand M.A., Brown C.S., Aarons E.,Tong C., Langrish C., Hoschler K., Brown K., Galiano M., Myers R., Pebody R.G., Green H.K., Boddington N.L., Gopal R., Price N.,Newsholme W., Drosten C., Fouchier R.A., Zambon M. Severe respiratory illness caused by a novel coronavirus, in a patient transferredto the United Kingdom from the Middle East, September 2012. Euro Surveill. 2012; 17(40):pii 20290.
18. Cauchemez S., Fraser C., Van Kerkhove M.D., Donnelly C.A., Riley S., Rambaut A., Enouf V., van der Werf S., FergusonN.M. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility.Lancet Infect. Dis. 2014; 14(1):50-6.
19. Cauchemez S., Van Kerkhove M.D., Riley S., Donnelly C.A., Fraser C., Ferguson N.M. Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill. 2013; 18(24):pii 20503.

103-429-432-3-31-2020-